Coordinate Regulation of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 Expression in Human Vascular Smooth Muscle Cells

References

• Chamley J. H., Campbell G. R., Burnstock G. Dedifferentiation, redifferentiation, and bundle formation of smooth muscle cells in tissue culture: the influence of cell number and nerve fibers. J. Embryol. Exp. Morphol 1974; 32: 297–323
   PubMedGoogle Scholar
• Chamley‐Campbell J. H., Champbell G. R., Ross R. Phenotype‐dependent response of cultured aortic smooth muscle to serum mitogens. J. Cell. Biol 1981; 89: 379–383
   PubMed Web of Science ®Google Scholar
• Thyberg J., Hedin U., Sjolund M., Palmberg L., Bottger B. A. Regulation of differentiated properties and proliferation of arterial smooth muscle cells. Arteriosclerosis 1990; 10: 966–990
   PubMedGoogle Scholar
• Owens G. K., Loeb A., Gordon D., Thompson M. M. Expression of smooth muscle‐specific α‐isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation. J. Cell. Biol 1986; 102: 343–352
   PubMed Web of Science ®Google Scholar
• Majors A. K., Ehrhart L. A. Cell density and proliferation modulate collagen synthesis and procollagen mRNA levels in arterial smooth muscle cells. Exp. Cell. Res 1992; 200: 168–174
   PubMed Web of Science ®Google Scholar
• Ang A. H., Tachas G., Campbell J. H., Bateman J. F., Campbell G. R. Collagen synthesis by cultured rabbit aortic smooth muscle cells alteration with phenotype. Biochem. J 1990; 265: 461–469
   PubMed Web of Science ®Google Scholar
• Holderbaum D., Ehrhart L. A. Modulation of types I and III procollagen synthesis at various stages of arterial smooth muscle cell growth in vitro. Exp. Cell. Res 1984; 153: 16–24
   PubMed Web of Science ®Google Scholar
• Timpl R. Structure and biological activity of basement membrane proteins. Eur. J. Biochem 1989; 180: 487–502
   PubMedGoogle Scholar
• Lyons‐Giordano B., Conaway H., Kefalides N. A. The effect of heparin on fibronectin and thrombos‐pondin synthesis by human smooth muscle cells. Biochem. Biophys. Res. Commun 1987; 148: 1264–1269
   PubMed Web of Science ®Google Scholar
• Cizmeci‐Smith G., Langan E., Youkey J., Showalter L. J., Carey D. J. Syndecan‐4 is a primary‐response gene induced by basic fibroblast growth factor and arterial injury in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol 1997; 17: 172–180
   PubMed Web of Science ®Google Scholar
• Liau G., Chan L. M. Regulation of extracellular matrix RNA levels in cultured smooth muscle cells relationship to cellular quiescence. J. Biol. Chem, 264: 10315–10320
   PubMed Web of Science ®Google Scholar
• Sjölund M., Madsen K., von der Mark K., Thyberg J. Phenotype modulation in primary cultures of smooth muscle cells from rat aorta. Synthesis of collagen and elastin. Differentiation 1986; 32: 173–180
   PubMed Web of Science ®Google Scholar
• Nagase H., Barrett A., Woessner J. F., Jr. Nomenclature and glossary of the matrix metalloprotei‐nases. Matrix (Suppl.) 1992; 1: 421–424
   PubMedGoogle Scholar
• Dollery C. M., McEwan J. R., Henney A. M. Matrix metalloproteinases and cardiovascular disease. Circ. Res 1995; 77: 863–868
   PubMed Web of Science ®Google Scholar
• Fabunmi R. P., Baker A. H., Murray E. J., Booth R. F., Newby A. C. Divergent regulation by growth factors and cytokines of 95 and 72 kDa gelatinases and tissue inhibitors or metalloproteinases‐1, ‐2, and ‐3 in rabbit aortic smooth muscle cells. Biochem. J 1996; 315(Pt. 1)335–342
   PubMedGoogle Scholar
• Kennedy S. H., Qin H., Lin L., Tan E. M. Basic fibroblast growth factor regulates type I collagen and collagenase gene expression in human smooth muscle cells. Am. J. Pathol 1995; 146: 764–771
   PubMed Web of Science ®Google Scholar
• Yanagi H., Sasaguri Y., Sugama K., Morimatsu M., Nagase H. Production of tissue collagenase (matrix metalloproteinase 1) by human aortic smooth muscle cells in response to platelet‐derived growth factor. Atherosclerosis 1992; 91: 207–216
   Web of Science ®Google Scholar
• Sasaguri Y., Murahashi N., Sugama K., Kato S., Hiraoka K., Satoh T., Isomoto H., Morimastu M. Development‐related changes in matrix metalloproteinase expression in human aortic smooth muscle cells. Lab. Invest 1994; 71: 261–269
   PubMed Web of Science ®Google Scholar
• Tyagi S. C., Meyer L., Schmaltz R. A., Reddy H. K., Voelker D. J. Proteinases and restenosis in the human coronary artery: extracellular matrix production exceeds theexpressionofproteolyticactivity. Atherosclerosis 1995; 116: 43–57
   PubMed Web of Science ®Google Scholar
• Tyagi S. C., Meyer L., Kumar S., Schmaltz R. A., Reddy H. K., Voelker D. J. Induction of tissue metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Can. J. Cardiol 1996; 12: 353–362
   PubMed Web of Science ®Google Scholar
• Nikkari S. T., Geary R. L., Hatsukami T., Ferguson M., Forough R., Alpers C. E., Clows A. W. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinase‐1 in restenosis after carotid endarterectomy. Am. J. Pathol 1996; 148: 777–783
   PubMed Web of Science ®Google Scholar
• Nikkari S. T., O'Brien K. D., Ferguson M., Hatsukami T., Welgus H. G., Alpers C. E., Clowes A. W. Interstitial collagenase (MMP‐1) expression in human carotid atherosclerosis. Circulation 1995; 92: 1393–1398
   PubMed Web of Science ®Google Scholar
• Li Z., Li L., Zielke H. R., Cheng L., Xiao R., Crow M. T., Stetler‐Stevenson W. G., Froehlich J., Lakatta E. G. Increased expression of 72‐kd type IV collagenase (MMP‐2) in human aortic atherosclerotic lesions. Am. J. Pathol 1996; 148: 121–128
   PubMed Web of Science ®Google Scholar
• Galis Z. S., Sukhova G. K., Lark M. W., Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest 1992; 94: 2493–2503
   Web of Science ®Google Scholar
• Galis Z. S., Muszynski M., Sukhova G. K., Simon‐Morrissey E., Libby P. Enhanced expression of vascular matrix metalloproteinases induced in vitro by cytokines and in regions of human atherosclerotic lesions. Ann. N.Y. Acad. Sci 1995; 748: 501–507
   PubMed Web of Science ®Google Scholar
• Pauly R. R., Passaniti A., Bilato C., Monticone R., Cheng L., Papadopoulos N., Gluzband Y. A., Smith L., Weinstein C., Lakatta E. G., Crow M. T. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res 1994; 75: 41–54
   PubMed Web of Science ®Google Scholar
• Bendeck M. P., Zempo N., Clowes A. W., Galardy R. E., Reidy M. A. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res 1994; 75: 539–545
   PubMed Web of Science ®Google Scholar
• Galis Z. S., Muszynski M., Sukohova G. K., Simon‐Morrissey E., Unemori E. N., Lark M. W., Amento E., Libby P. Cytokine‐stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res 1994; 75: 181–189
   PubMed Web of Science ®Google Scholar
• Galis Z. S., Sukhova G. K., Libby P. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 1995; 9: 974–980
   PubMed Web of Science ®Google Scholar
• Brown D. L., Hibbs M. S., Kearney M., Loushin C., Isner J. M. Identification of 92‐kDa gelatinase in human coronary atherosclerotic lesions association of active enzyme synthesis with unstable angina. Circulation 1995; 91: 2125–2131
   PubMed Web of Science ®Google Scholar
• Knox J. B., Sukhova G. K., Whittemore A. D., Libby P. Evidence for altered balance between matrix metalloproteinase and their inhibitors in human aortic diseases. Circulation 1997; 95: 205–212
   PubMed Web of Science ®Google Scholar
• Kato S., Shanley J. R., Fox J. C. Serum stimulation, cell‐cell interactions, and extracellular matrix independently influence smooth muscle cell phenotype in vitro. Am. J. Pathol 1996; 149: 687–697
   PubMed Web of Science ®Google Scholar
• Freshney R. I. Culture of animal cells, a manual of basic technique2nd edn, R. I. Freshney. Alan R. Liss Inc., New York 1987; 113–115
   Google Scholar
• Gratzner H. G. Monoclonal antibody to 5‐bromo‐and 5‐iododeoxyuridine: a new reagent for detection of DNA replication. Science 1982; 218: 474–475
   PubMed Web of Science ®Google Scholar
• Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J. Immunol. Methods 1983; 65: 55–63
   PubMed Web of Science ®Google Scholar
• Zhang J., Fujimoto N., Iwata K., Sakai T., Okada Y., Hayakawa T. A. One‐step sandwich enzyme immunoassay for human matrix metalloproteinase‐1 (interstitial collagenase) using monoclonal antibodies. Clin. Chim. Acta 1993; 219: 1–14
   PubMed Web of Science ®Google Scholar
• Kodama S., Iwata H., Yamashita K., Hayakawa T. Rapid one‐step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases, an application for rheumatoid arthritis serum and plasma. J. Immunol. Methods 1990; 127: 103–108
   PubMed Web of Science ®Google Scholar
• Herron G. S., Werb Z., Dwyer K., Banada M. J. Secretion of metalloproteinases by stimulated capillary endothelial cells. I. Production of procollagenases and prostromelysin exceeds expression of proteolytic activity. J. Biol. Chem 1986; 261: 2814–2818
   PubMed Web of Science ®Google Scholar
• Harris E. D., Jr., Vater C. A. Vertebrate collagenases. Methods in Enzymology 1982; 82: 423–452
   PubMed Web of Science ®Google Scholar
• Lee S. H., Hurwitz J. Mechanism of elongation of primed DNA by DNA polymerase delta, proliferating cell nuclear antigen, and activator 1. Proc. Natl. Acad. Sci 1990; 87: 5672–5676
   PubMed Web of Science ®Google Scholar
• Baker A. H., Zaltsman A. B., George S. J., Newby A. C. Divergent effects of tissue inhibitor of metalloproteinase‐1, ‐2, or ‐3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro TIMP‐3 promotes apoptosis. J. Clin. Invest 1998; 101: 1478–1487
   PubMed Web of Science ®Google Scholar
• Murahashi N., Sasaguri Y., Ohuchida M., Kakita N., Morimatsu M. Immortalization of human aortic smooth muscle cells with ori‐mimus SV 40 DNA. Biotech. and Appl. Biochem 1992; 16: 152–160
   PubMed Web of Science ®Google Scholar
• Zempo N., Kenagy R. D., Au Y. P., Bendeck M., Clowes M. M., Reidy M. A., Clowes A. W. Matrix metalloproteinase of vascular wall cells are increased in balloon‐injured rat carotid artery. J. Vase. Surg 1994; 20: 209–217
   PubMed Web of Science ®Google Scholar
• Mayne R. Collagenous proteins of blood vessels. Arteriosclerosis 1986; 6: 585–593
   PubMedGoogle Scholar
• Goldberg G. I., Wilhelm S. M., Kronberger A., Bauer E. A., Grant G. A., Eisen A. Z. Human fibroblast collagenase. Complete primary structure and homology to an oncogene transformation‐induced rat protein. J. Biol. Chem 1986; 261: 6600–6605
   PubMed Web of Science ®Google Scholar
• Docherty A. J., Lyons A., Smith B. J., Wright E. M., Stephens P. E., Harris T. J., Murphy G., Reynolds J. J. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid‐potentiating activity. Nature (London) 1985; 318: 66–69
   PubMed Web of Science ®Google Scholar
• Stetler‐Stevenson W. G., Krutzsch H. C., Liotta L. A. Tissue inhibitor of metalloproteinase (TIMP‐2). A new member of the metalloproteinase inhibitor family. J. Biol. Chem 1989; 264: 17374–17378
   PubMed Web of Science ®Google Scholar
• Howard E. W., Bullen E. X., Banda M. J. Preferential inhibition of 72‐ and 92‐kDa gelatinases by tissue inhibitor of metalloproteinases‐2. J. Biol. Chem 1991; 266: 13070–13075
   PubMed Web of Science ®Google Scholar
• Wang H., Moore S., Alavi M. Z. Synthesis of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in rabbit aortic neointima after selective de‐endothelialization. Atherosclerosis 1996; 126: 95–104
   PubMed Web of Science ®Google Scholar
• Fabunmi R. P., Sukhova G. K., Sugiyama S., Libby P. Expression of tissue inhibitor of metalloproteinase‐3 in human atheroma and regulation in lesion‐associated cells. A potential protective mechanism in plaque stability. Circ. Res 1998; 83: 270–278
   PubMed Web of Science ®Google Scholar
• Shima I., Sasaguri Y., Kusukawa J., Nakano R., Yamana H., Fujita H., Kakegawa T., Morimatsu M. Production of matrix metalloproteinase 9 (92kDa gelatinase) by human esophageal squamous cell carcinoma in response to epidermal growth factor. Br. J. Cancer 1993; 67: 721–727
   PubMed Web of Science ®Google Scholar
• Hiraoka K., Sasaguri Y., Komiya S., Zynmyo M., Inoue A., Morimatsu M. Effect of lipid peroxide on the production of matrix metalloproteinases by rheumatoid synovial fibroblasts. Exp. Mol. Pathol 1993; 59: 169–176
   PubMed Web of Science ®Google Scholar
• Greene J., Wang M., Liu Y. E., Raymond L. A., Rosen C., Shi Y. E. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J. Biol. Chem 1996; 271: 30375–30380
   PubMed Web of Science ®Google Scholar
• Dollery C. M., McEwan J. R., Wang M., Sang Q. A., Liu Y. E., Shi Y. E. TIMP‐4 is regulated by vascular injury in rats. Circ. Res 1999; 84: 498–504
   PubMed Web of Science ®Google Scholar
• Nagase H., Suzuki K., Morodomi T., Enghild J. J., Salvesen G. Activation mechanisms of the precursors of matrix metalloproteinases 1, 2 and 3. Matrix. (Suppl.) 1992; 1: 237–244
   PubMedGoogle Scholar
• Sato H., Kida Y., Mai M., Endo Y., Sasaki T., Tanaka J., Seiki M. Expression of genes encoding type IV collagen‐degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7: 77–85
   PubMed Web of Science ®Google Scholar
• Li Z., Froehlich J., Galis Z. S., Lakatta E. G. Increased expression of matrix metalloproteinase‐2 in the thickened intima of aged rats. Hypertension 1999; 33: 116–123
   PubMed Web of Science ®Google Scholar
• Ross R. The pathologenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809
   PubMed Web of Science ®Google Scholar